Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Tioma Therapeutics
2000 Sierra Point Parkway Suite 700
Brisbane, CA 94005
Phone: 415-671-4024
https://www.tiomatherapeutics.com/

The company has generated a portfolio of anti-CD47 antibodies that have the potential to surmount multiple checkpoints by which cancer evades the immune system. These antibodies are protected by a strong, multilayered intellectual property estate that includes composition-of-matter and uses of humanized anti-CD47 antibodies.

Key Contact
Name
John Donovan
Title
President and CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
08/16/16 $86,000,000 Series A Novo Ventures
RiverVest Venture Partners
Roche Venture Fund
SR One
undisclosed